Petr Janský
Impact in
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac electrophysiology and arrhythmias
- Acute Myocardial Infarction Research
Papers in
-
- Atrial Fibrillation Management and Outcomes 27
- Acute Myocardial Infarction Research 9
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Blood Pressure and Hypertension Studies 3
-
- Diabetes Treatment and Management 7
- Co-authors
- Lars C. Wallentin (9 shared papers)Renato Delascio Lopes (9 shared papers)John Alexander (6 shared papers)Christopher Bull Granger (4 shared papers)Michael G. Hanna (5 shared papers)Elaine M. Hylek (4 shared papers)Claes Held (6 shared papers)Laine Elliott Thomas (3 shared papers)
- Journals
- European Heart Journal (7 papers)The Lancet (6 papers)Journal of the American College of Cardiology (5 papers)New England Journal of Medicine (5 papers)Circulation (4 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Petr Janský
70 papers receiving 17.3k citations
Petr Janský's Hit Papers
Peers
Comparison fields: 5 of 131
- Internal Medicine 3.6k
- Cardiology and Cardiovascular Medicine 11.6k
- Endocrinology, Diabetes and Metabolism 2.9k
- Family Practice 115
- Surgery 2.4k
Countries citing papers authored by Petr Janský
This map shows the geographic impact of Petr Janský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Janský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Janský more than expected).
Fields of papers citing papers by Petr Janský
This network shows the impact of papers produced by Petr Janský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Janský. The network helps show where Petr Janský may publish in the future.
Co-authors
The 25 scholars most cited alongside Petr Janský, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apixaban versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 7049 |
| 2 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 3 | Apixaban in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 1914 |
| 4 | Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome Hit paper breakdown → | 2011 | 788 |
| 5 | Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 683 |
| 6 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 671 |
| 7 | Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2017 | 607 |
| 8 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 9 | 2014 | 298 | |
| 10 | Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease Hit paper breakdown → | 2016 | 297 |
| 11 | 2014 | 293 | |
| 12 | 2014 | 284 | |
| 13 | 2014 | 268 | |
| 14 | 2018 | 238 | |
| 15 | 2016 | 231 | |
| 16 | 2016 | 205 | |
| 17 | 2013 | 177 | |
| 18 | 2010 | 153 | |
| 19 | 2017 | 148 | |
| 20 | 2009 | 99 |
About Petr Janský
Petr Janský is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Internal Medicine, Surgery and Pharmacology, having authored 74 papers that have together received 18.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (27 papers), Acute Myocardial Infarction Research (9 papers), Diabetes Treatment and Management (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Lipoproteins and Cardiovascular Health (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Blood Pressure and Hypertension Studies (3 papers) and Cardiac Imaging and Diagnostics (3 papers). The work is most often cited by research in Internal Medicine (3.6k citations), Cardiology and Cardiovascular Medicine (11.6k citations), Endocrinology, Diabetes and Metabolism (2.9k citations), Family Practice (115 citations) and Surgery (2.4k citations). Petr Janský has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Lars C. Wallentin, Renato Delascio Lopes, John Alexander, Christopher Bull Granger, Michael G. Hanna, Elaine M. Hylek, Claes Held, Laine Elliott Thomas, Sigrun Halvorsen and Salim Yusuf. Their work appears in journals such as European Heart Journal, The Lancet, Journal of the American College of Cardiology, New England Journal of Medicine and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.